DK523881A - Fremgangsmaade til udvinding af interferon fra bakterier - Google Patents

Fremgangsmaade til udvinding af interferon fra bakterier

Info

Publication number
DK523881A
DK523881A DK523881A DK523881A DK523881A DK 523881 A DK523881 A DK 523881A DK 523881 A DK523881 A DK 523881A DK 523881 A DK523881 A DK 523881A DK 523881 A DK523881 A DK 523881A
Authority
DK
Denmark
Prior art keywords
extracing
interferon
bacteria
procedure
extracing interferon
Prior art date
Application number
DK523881A
Other languages
English (en)
Other versions
DK158475B (da
DK158475C (da
Inventor
P Leibowitz
M J Weinstein
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK523881A publication Critical patent/DK523881A/da
Publication of DK158475B publication Critical patent/DK158475B/da
Application granted granted Critical
Publication of DK158475C publication Critical patent/DK158475C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/555Interferons [IFN]
    • C07K14/56IFN-alpha
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/005Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor after treatment of microbial biomass not covered by C12N1/02 - C12N1/08
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/811Interferon
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82Proteins from microorganisms
    • Y10S530/825Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Sustainable Development (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK523881A 1980-11-26 1981-11-25 Fremgangsmaade til fremstilling af interferon eller en interferonoploesning fra interferonproducerende bakterier. DK158475C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21042680A 1980-11-26 1980-11-26
US21042680 1980-11-26
US06/221,135 US4315852A (en) 1980-11-26 1980-12-29 Extraction of interferon from bacteria
US22113580 1980-12-29

Publications (3)

Publication Number Publication Date
DK523881A true DK523881A (da) 1982-05-27
DK158475B DK158475B (da) 1990-05-21
DK158475C DK158475C (da) 1990-10-15

Family

ID=26905139

Family Applications (1)

Application Number Title Priority Date Filing Date
DK523881A DK158475C (da) 1980-11-26 1981-11-25 Fremgangsmaade til fremstilling af interferon eller en interferonoploesning fra interferonproducerende bakterier.

Country Status (9)

Country Link
US (1) US4315852A (da)
EP (1) EP0052861B1 (da)
CA (1) CA1176980A (da)
DE (1) DE3163675D1 (da)
DK (1) DK158475C (da)
FI (1) FI70927C (da)
HK (1) HK14187A (da)
IE (1) IE51858B1 (da)
IL (1) IL64385A (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI88175C (fi) 1980-04-03 1993-04-13 Biogen Inc Rekombinant-dna-molekyler och foerfaranden foer framstaellning av polypeptider liknande humant -interferon
US4450103A (en) * 1982-03-01 1984-05-22 Cetus Corporation Process for recovering human IFN-β from a transformed microorganism
US4925919A (en) * 1984-04-25 1990-05-15 Roland Mertelsmann Purified interleukin 2
US4992271A (en) * 1982-09-23 1991-02-12 Cetus Corporation Formulation for lipophilic IL-2 proteins
US4462940A (en) * 1982-09-23 1984-07-31 Cetus Corporation Process for the recovery of human β-interferon-like polypeptides
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US4853332A (en) * 1982-10-19 1989-08-01 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins
JP2551746B2 (ja) * 1983-07-19 1996-11-06 サントリー株式会社 改良プラスミドベクタ−およびその利用
US4569790A (en) * 1984-03-28 1986-02-11 Cetus Corporation Process for recovering microbially produced interleukin-2 and purified recombinant interleukin-2 compositions
US4908433A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Uses of interleukin-2
US4908434A (en) * 1984-04-25 1990-03-13 Sloan-Kettering Institute For Cancer Research Process for preparing purified interleukin-2
DE3432196A1 (de) * 1984-09-01 1986-03-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Neues mechanisches aufschlussverfahren von bakterienzellen zur isolierung von rekombinant hergestellten peptiden
US4675387A (en) * 1985-07-26 1987-06-23 E. I. Du Pont De Nemours And Company Method for extracting protein with organic acid
WO1991018927A1 (en) * 1990-06-04 1991-12-12 Schering Corporation Method for preparing interferon alpha-2 crystals
US5441734A (en) * 1993-02-25 1995-08-15 Schering Corporation Metal-interferon-alpha crystals
US6399296B1 (en) * 1994-07-20 2002-06-04 The General Hospital Corporation Interaction trap systems for detecting protein interactions
US6281337B1 (en) 1998-11-12 2001-08-28 Schering Corporation Methods for conversion of protein isoforms
ATE409706T1 (de) 1998-11-12 2008-10-15 Schering Corp Verfahren zur umwandlung von interferon-isoformen und daraus hergestellte produkte
AR034749A1 (es) * 2001-07-09 2004-03-17 Schering Ag Formulaciones de interferon beta humano
GB0319601D0 (en) 2003-08-20 2003-09-24 Sandoz Ag Production process
CZ2007695A3 (cs) 2005-04-11 2008-02-27 Savient Pharmaceuticals, Inc. Variantní formy urátoxidázy a jejich použití
HU230758B1 (hu) * 2006-04-12 2018-03-28 Crealta Pharmaceuticals LLC 100% Fehérjék tisztítása kationos felületaktív anyaggal
EP2382237A1 (en) 2008-12-23 2011-11-02 Schering Corporation Purification of recombinantly produced interferon
SG176897A1 (en) 2009-06-25 2012-01-30 Savient Pharmaceuticals Inc Methods and kits for predicting infusion reaction risk and antibody-mediated loss of response by monitoring serum uric acid during pegylated uricase therapy

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3699222A (en) * 1958-03-11 1972-10-17 Nat Res Dev Production of viral interfering substances
GB980227A (en) * 1962-08-16 1965-01-13 Glaxo Lab Ltd Purification and/or concentration of material containing interferon
GB1055895A (en) * 1963-12-10 1967-01-18 Glaxo Lab Ltd Interferon purification
US3256152A (en) * 1965-06-14 1966-06-14 Merck & Co Inc Concentration and purification of interferons, viral inhibiting substances (vis), viral inhibiting factors (vif), or viral inhibitory material
EP0005476B1 (de) * 1978-05-17 1981-12-30 Dr. Karl Thomae GmbH Verfahren zur Herstellung von Humaninterferon
US4262090A (en) * 1979-06-04 1981-04-14 Cetus Corporation Interferon production

Also Published As

Publication number Publication date
IE812767L (en) 1982-05-26
IL64385A0 (en) 1982-02-28
FI813785L (fi) 1982-05-27
DK158475B (da) 1990-05-21
EP0052861B1 (en) 1984-05-16
IE51858B1 (en) 1987-04-15
US4315852A (en) 1982-02-16
EP0052861A3 (en) 1983-01-26
DK158475C (da) 1990-10-15
EP0052861A2 (en) 1982-06-02
DE3163675D1 (en) 1984-06-20
CA1176980A (en) 1984-10-30
FI70927B (fi) 1986-07-18
FI70927C (fi) 1986-10-27
IL64385A (en) 1984-09-30
HK14187A (en) 1987-02-27

Similar Documents

Publication Publication Date Title
DK523881A (da) Fremgangsmaade til udvinding af interferon fra bakterier
DK376381A (da) Fremgangsmaade til mikroindkapsling
DK29881A (da) Fremgangsmaade til fremsilling af polyetherforbindelser
DK292781A (da) Semipermeable iembraner
DK158222C (da) Fremgangsmaade til udvinding af betain fra melasse
DK208982A (da) Fremgangsmaade til ombytning af delbaand
DK211181A (da) Fremgangsmaade til fremstilling af alfachlorerede chlorformiater
DK354281A (da) Fremgangsmaade til geninkorporering af kakaoaroma
DK95281A (da) Fremgangsmaade til fremstilling af genetisk modificerede mikroorganismer
BR8006168A (pt) Controlador digital de volume
AT385158B (de) Schaltung zur stoerungsunterdrueckung
DK323081A (da) Kompenseret referencevaeske
DK115581A (da) Fremgangsmaade til fremstilling af pyrimidylquinazoliner
DK316981A (da) Fremgangsmaade til fremstilling af pentapeptider
FI813674L (fi) Slaeckningskrets foer videosignal foersedd med styrd oeppningshastighet foer elektronstraolen
FI812586L (fi) Nycklingssignalgenerator utan falsk utgaong
DK369181A (da) Fremgangsmaade til fremstilling af triazolylvinylketonforbindelser
DK142381A (da) Fremgangsmaade til fremstilling af substituerede triarylthiazolforbindelser
DK166581A (da) Fremgangsmaade til fremstilling af peptider
DK449881A (da) Fremgangsmaade til fremstilling af moroxydinphenoxyisobutyrater
FI811473L (fi) Modulatorer foer immunsystem
DK558581A (da) Forbindelsesbeslag
DK380981A (da) Fremgangsmaade til fremstilling af benzoquinoliziner
DK411881A (da) Fremgangsmaade til fremstilling af 1-oxa-beta-lactamantibiotika
DK362381A (da) Fremgangsmaade til fremstilling af polyazaheterocycliske fordelser